Page 80 - IJB-9-3
P. 80

International Journal of Bioprinting                        3DP hydrogels to combat antibiotic-resistant bacteria






























                Figure 5. In vitro cumulative release and concentration of Rif (a, c) and Van (b, d) from LMW, MMW, and HMW PLGA NPs in PBS at 37°C.















                          Figure 6. Development of resistance of S. aureus RN4220 against Rif (a) and Van (b) over 25 passages (n = 2).
                       R
            RN4220 Van  for subsequent experiments to maintain   Van-NPs  hydrogels with a ZOI  for 5 days  (Figure  7c).
            its resistance.                                    Hence, the high local release of Van was still able to kill
                                                               Van-resistant bacteria. The clinical S. aureus strain AMC
            3.7. Antibacterial activity of GelMA-PLGA NPs      201 had a ZOI with the GelMA-Rif-NPs, GelMA-Van-NPs,
            hydrogels over time                                or GelMA-Rif-Van-NPs hydrogels for 3, 6, and 3  days,
            GelMA-Rif-NPs, GelMA-Van-NPs, and GelMA-Rif-       respectively. As expected, GelMA-C-NPs hydrogels did
            Van-NPs hydrogels were transferred to fresh agar   not form any ZOI for any S. aureus strain (not shown). In
            plates  inoculated  with  different  test  strains  on  a  daily   summary, the GelMA-Rif-NPs hydrogels formed ZOI for
            basis, and they created a zone of inhibition (ZOI) that   S. aureus RN4220, S. aureus RN4220 Van , and S. aureus
                                                                                                 R
            prevented bacterial growth for S. aureus RN4220 for 10,   AMC201, but not for S. aureus RN4220 Rif . The GelMA-
                                                                                                 R
            9, and 10 days, respectively, with diameters of the zones   Van-NPs hydrogels formed ZOI for the four  S. aureus
            decreasing over time as expected with the release of the   strains, with S. aureus RN4220 Van  being less susceptible
                                                                                           R
            antibiotics (Figure 7a). The GelMA-Van-NPs or GelMA-  and S. aureus RN4220 Rif  more susceptible than the other
                                                                                   R
                                                       R
            Rif-Van-NPs showed a ZOI for S. aureus RN4220 Rif  for   strains. The GelMA-Rif-Van-NPs hydrogels formed ZOI
            7 and 5 days, respectively (Figure 7b). S. aureus RN4220   for all S. aureus strains, showing that this double antibiotic-
            Rif  showed to be more sensitive for the GelMA-Van-NPs   releasing hydrogel targets both resistant strains.
              R
            than the other S. aureus strains as it showed a larger ZOI.
            As expected, no ZOI formed around the GelM-Rif-NPs for   3.8. Antimicrobial and anti-adhesive activity of the
            S. aureus RN4220 Rif , meaning that the release of Rif did   3D-printed GelMA hydrogels loaded with Rif-NPs
                             R
            not inhibit the bacterial growth. S. aureus RN4220 Van    and Van-NPs
                                                          R
            showed to be slightly more sensitive to GelMA-Rif-NPs   In vitro antimicrobial and antiadhesive activity of the
            with a ZOI for 10 days and less susceptible to the GelMA-  GelMA-Rif-NPs, GelMA-Van-NPs, or GelMA-Rif-Van-NPs
            Volume 9 Issue 3 (2023)                         72                         https://doi.org/10.18063/ijb.683
   75   76   77   78   79   80   81   82   83   84   85